Literature DB >> 20864699

Professor Natan Goldblum: the pioneer producer of the inactivated poliomyelitis vaccine in Israel.

Nava Blum1, Ehud Katz, Elizabeth Fee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20864699      PMCID: PMC2951960          DOI: 10.2105/AJPH.2010.192922

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  4 in total

1.  Antigenic activity of poliomyelitis vaccines undergoing field test.

Authors:  J E SALK; L J LEWIS; B L BENNETT; E N WARD; U KRECH; J S YOUNGER; P L BAZELEY
Journal:  Am J Public Health Nations Health       Date:  1955-02

2.  The polio epidemic in Israel in the 1950s.

Authors:  Nava Blum; Elizabeth Fee
Journal:  Am J Public Health       Date:  2006-12-28       Impact factor: 9.308

3.  Production of formalinized poliomyelitis vaccine (Salk-type) on a semi-industrial scale.

Authors:  N GOLDBLUM; T GOTLIEB; G MILLER
Journal:  Bull World Health Organ       Date:  1957       Impact factor: 9.408

Review 4.  Poliomyelitis control in Israel, the West Bank and Gaza Strip: changing strategies with the goal of eradication in an endemic area.

Authors:  N Goldblum; C B Gerichter; T H Tulchinsky; J L Melnick
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

  4 in total
  1 in total

1.  Professor Natan Goldblum and the combined vaccination program in Gaza.

Authors:  Ted Tulchinsky
Journal:  Am J Public Health       Date:  2011-05       Impact factor: 9.308

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.